4 Aug 2025

US Tariffs 2.0: how can Switzerland secure a better deal?

Switzerland said it was confident about securing an early trade deal as it was willing to pledge nearly $150bn in US-bound investment (which is huge on relative terms). “We have nine million people in Switzerland, yet our investment pledge per capita is much more than what Japan or the EU have pledged. If we talk about a $40bn trade deficit, one has to put that [in] perspective,” said Rahul Sahgal, chief executive of the Swiss-American Chamber of Commerce. Let’s also keep in mind that we are also a huge investor in the US, with Nestlé, Roche and Novartis employing thousands of Americans. Gold exports — often transiting through Switzerland for refining or trade — are largely responsible for the country’s trade imbalance with the US. Yet both gold and pharmaceutical products are exempt from Trump’s “reciprocal tariffs. Pharmaceutical sector could be the tipping point: Switzerland’s pharma sector sends about 60% of its exports to the US. Novartis and Roche’s US subsidiary Genentech were among the pharmaceutical companies that received letters from the Trump administration this week demanding that they lower drug prices. Swiss watchmaker Breitling’s CEO Georges Kern said his country was being “held hostage” by the pharmaceutical industry that had irritated Trump. Source: FT

Disclaimer

This marketing document has been issued by Bank Syz Ltd. It is not intended for distribution to, publication, provision or use by individuals or legal entities that are citizens of or reside in a state, country or jurisdiction in which applicable laws and regulations prohibit its distribution, publication, provision or use. It is not directed to any person or entity to whom it would be illegal to send such marketing material. This document is intended for informational purposes only and should not be construed as an offer, solicitation or recommendation for the subscription, purchase, sale or safekeeping of any security or financial instrument or for the engagement in any other transaction, as the provision of any investment advice or service, or as a contractual document. Nothing in this document constitutes an investment, legal, tax or accounting advice or a representation that any investment or strategy is suitable or appropriate for an investor's particular and individual circumstances, nor does it constitute a personalized investment advice for any investor. This document reflects the information, opinions and comments of Bank Syz Ltd. as of the date of its publication, which are subject to change without notice. The opinions and comments of the authors in this document reflect their current views and may not coincide with those of other Syz Group entities or third parties, which may have reached different conclusions. The market valuations, terms and calculations contained herein are estimates only. The information provided comes from sources deemed reliable, but Bank Syz Ltd. does not guarantee its completeness, accuracy, reliability and actuality. Past performance gives no indication of nor guarantees current or future results. Bank Syz Ltd. accepts no liability for any loss arising from the use of this document.

Read More

Straight from the Desk

Syz the moment

Live feeds, charts, breaking stories, all day long.

Thinking out loud

Sign up for our weekly email highlighting the most popular posts.

Follow us

Thinking out loud

Investing with intelligence

Our latest research, commentary and market outlooks